Auteurs
Analysis
UK
Racine
Analysis
UK
Exploration
Accueil
Racine
Racine

Serveur d'exploration sur les relations entre la France et l'Australie - Analysis (UK)

Index « Auteurs » - entrée « J. Maroun »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
J. Markowitz < J. Maroun < J. Marque  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 2.
Ident.Authors (with country if any)Title
003552 (2002) J. Cassidy [Royaume-Uni] ; C. Twelves [Royaume-Uni] ; E. Van Cutsem [Belgique] ; P. Hoff [États-Unis] ; E. Bajetta [Italie] ; M. Boyer [Australie] ; R. Bugat [France] ; U. Burger [Suisse] ; A. Garin [Russie] ; U. Graeven [Allemagne] ; J. Mckendrick [Australie] ; J. Maroun [Canada] ; J. Marshall [États-Unis] ; B. Osterwalder [Suisse] ; G. Pe Rez-Manga [Espagne] ; R. Rosso [Italie] ; P. Rougier [France] ; R. L. Schilsky [États-Unis]First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin
003601 (2002) D. Cunningham [Royaume-Uni] ; J. Zalcberg [Australie] ; J. Maroun [Canada] ; R. James [Royaume-Uni] ; S. Clarke [Australie] ; T. S. Maughan [Royaume-Uni] ; M. Vincent [Canada] ; J. Schulz [États-Unis] ; M. Gonzalez Baron [Espagne] ; T. Facchini [France]Efficacy, tolerability and management of raltitrexed (Tomudex) monotherapy in patients with advanced colorectal cancer: a review of phase II/III trials

List of associated KwdEn.i

Nombre de
documents		Descripteur
2Antineoplastic agent
2Chemotherapy
2Clearance
2Colon
2Creatinine
2Human
2Malignant tumor
2Rectum
2Toxicity
2Treatment
2Treatment efficiency
1Abnormality
1Advanced stage
1Adverse events
1Baseline
1Baseline capecitabine dose
1Baseline creatinine clearance
1Baseline dose
1Biological monitoring
1Calcium folinate
1Capecitabine
1Capecitabine group
1Capecitabine scheme
1Clin oncol
1Clinical trial
1Colorectal
1Colorectal cancer
1Comparative study
1Creatinine clearance
1Disease progression
1Dose
1Dose modification
1Dose reduction
1Dose reductions
1Drug combination
1Enzyme inhibitor
1Equivalent survival
1Equivalent time
1Favorable safety profile
1First dose modification
1Fluoropyrimidine derivatives
1Fluorouracil
1Further grade
1Higher incidence
1Impairment
1Intravenous administration
1Key words: capecitabine, colorectal cancer, fluoropyrimidine, tolerability
1Leucovorin
1Lower incidence
1Mayo clinic regimen
1Median
1Median duration
1Median time
1Metastatic
1Metastatic breast cancer
1Metastatic colorectal cancer
1Modification
1Oncology
1Oral administration
1Oral capecitabine
1Pharmacokinetic
1Pharmacokinetic study
1Phase II trial
1Phase III trial
1Progression
1Pyrimidine derivatives
1Raltitrexed
1Regression analysis
1Renal
1Renal function
1Rest period
1Safety data
1Safety population
1Safety profile
1Serum creatinine
1Stomatitis
1Subpopulation
1Syndrome
1Systemic exposure
1Tolerance
1Treatment arms
1Treatment groups
1Treatment interruption
1Tumor tissue

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/UK/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/UK/Analysis/Author.i -k "J. Maroun" 

HfdIndexSelect -h $EXPLOR_AREA/Data/UK/Analysis/Author.i  \
                -Sk "J. Maroun" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/UK/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    UK
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    J. Maroun
}}
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024